Elite Pharmaceuticals, Inc. (ELTP)
0.2891
-0.01
(-2.00%)
USD |
OTCM |
Aug 24, 16:00
Elite Pharmaceuticals Price : 0.2891 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 0.2998 | 0.2999 | 0.2858 | 0.2891 | 700761.0 |
| Aug 21, 2026 | 0.3024 | 0.31 | 0.2844 | 0.295 | 900854.0 |
| Aug 20, 2026 | 0.3034 | 0.3075 | 0.29 | 0.2974 | 1.322M |
| Aug 19, 2026 | 0.305 | 0.305 | 0.2957 | 0.303 | 471998.0 |
| Aug 18, 2026 | 0.3081 | 0.318 | 0.303 | 0.3035 | 463177.0 |
| Aug 17, 2026 | 0.2976 | 0.324 | 0.29 | 0.308 | 1.133M |
| Aug 14, 2026 | 0.30 | 0.32 | 0.2720 | 0.31 | 5.893M |
| Aug 13, 2026 | 0.36 | 0.3749 | 0.355 | 0.3585 | 913100.0 |
| Aug 12, 2026 | 0.361 | 0.372 | 0.3558 | 0.36 | 1.069M |
| Aug 11, 2026 | 0.363 | 0.37 | 0.3601 | 0.361 | 439356.0 |
| Aug 10, 2026 | 0.3556 | 0.3699 | 0.3556 | 0.3601 | 323771.0 |
| Aug 07, 2026 | 0.36 | 0.365 | 0.3503 | 0.361 | 648849.0 |
| Aug 06, 2026 | 0.356 | 0.3676 | 0.3517 | 0.3577 | 216030.0 |
| Aug 05, 2026 | 0.371 | 0.3738 | 0.358 | 0.3609 | 298392.0 |
| Aug 04, 2026 | 0.378 | 0.378 | 0.3485 | 0.3649 | 582390.0 |
| Aug 03, 2026 | 0.3789 | 0.379 | 0.3572 | 0.3716 | 253657.0 |
| Jul 31, 2026 | 0.3652 | 0.379 | 0.3652 | 0.3789 | 104816.0 |
| Jul 30, 2026 | 0.3699 | 0.38 | 0.3582 | 0.3727 | 357797.0 |
| Jul 29, 2026 | 0.39 | 0.39 | 0.3661 | 0.3716 | 218748.0 |
| Jul 28, 2026 | 0.385 | 0.385 | 0.3652 | 0.375 | 216457.0 |
| Jul 27, 2026 | 0.3878 | 0.3899 | 0.3651 | 0.385 | 305286.0 |
| Jul 24, 2026 | 0.3678 | 0.395 | 0.3678 | 0.3875 | 616828.0 |
| Jul 23, 2026 | 0.36 | 0.379 | 0.36 | 0.375 | 179861.0 |
| Jul 22, 2026 | 0.361 | 0.379 | 0.361 | 0.373 | 223162.0 |
| Jul 21, 2026 | 0.39 | 0.39 | 0.3681 | 0.379 | 158667.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Nektar Therapeutics | 74.90 |
| Daré Bioscience, Inc. | 0.8208 |
| Eton Pharmaceuticals, Inc. | 62.94 |
| ANI Pharmaceuticals, Inc. | 75.60 |
| Corcept Therapeutics, Inc. | 123.54 |
Price Related Metrics
| PE Ratio | 10.99 |
| PS Ratio | 2.300 |
| Price to Book Value | 2.971 |
| Price to Free Cash Flow | 18.51 |
| Earnings Yield | 9.10% |
| Market Cap | 311.40M |
| Operating PE Ratio | 9.064 |
| Normalized PE Ratio | 35.69 |